Penn State
University Park, Pennsylvania, 16802, United States
NCT Number: NCT03826472
A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 2
University Park, Pennsylvania, 16802, United States
Control of fasting blood glucose is a challenge for many individuals with diabetes. Researchers want to better understand how a nighttime snack can affect morning fasting blood glucose. A two-period randomized crossover trial will be conducted. Participants will be randomized to receive each treatment for 1 week. During the almond butter treatment, participants will consume 2 tbsp of almond butter per day as an evening snack. The control treatments will be a no-snack control. Fasting blood glucose, as well as glucose trends, will be measured using Continuous Glucose Monitor (CGM). Participants will also be asked to take simple cognitive tests on a study-provided smartphone each day of the study and report their daily food intake and physical activity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Natural almond butter
Time frame: 2 weeks
Fasting glucose measures how much glucose (sugar) is in a blood sample after an overnight fast. In this study, fasting glucose was measured by continuous glucose monitoring (interstitial glucose); fasting window identified through review of glucose monitoring data to be 4am-6am.
Time frame: 2 weeks
Overnight (12pm-4am) mean blood sugar values measured by continuous glucose monitoring (interstitial glucose)
Time frame: 2 weeks
Go-NoGo task asked participants to press a button when a letter other than X was on screen and not press a button when X was present.
Looking for future studies?
Notify MePenn State University
Other
Almond Butter and Fasting Glucose in Adults With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04999124
Diabetes Mellitus, Diabetes Mellitus, Type 2
Genk, Belgium
View Trial DetailsNCT03923205
Diabetes Mellitus, Diabetes Mellitus, Type 2
Aberdeen, United Kingdom
View Trial DetailsNCT03955952
Bariatric Surgery Candidate, Body Weight
Cleveland, Ohio, United States
View Trial DetailsNCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial Details